134 filings
8-K
IVVD
Invivyd, Inc.
6 Sep 24
Other Events
9:05am
8-K
IVVD
Invivyd, Inc.
4 Sep 24
Other Events
7:10am
8-K
IVVD
Invivyd, Inc.
3 Sep 24
Center for Disease Control reports KP.3.1.1 is the only major variant increasing in proportionality nationally
7:07am
8-K
IVVD
Invivyd, Inc.
27 Aug 24
Other Events
8:05am
10-Q
2024 Q2
IVVD
Invivyd, Inc.
Quarterly report
14 Aug 24
8:25am
8-K
xg49dxu
14 Aug 24
Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights
8:20am
8-K
xbxtjlax1lv8npmx
14 Jun 24
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
7:07am
8-K
krf ye6dsc
31 May 24
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
7:12am
8-K
rcqubx4d9z
22 May 24
Invivyd Elects Two New Independent Members to its Board of Directors
7:06am
S-8
5woly
9 May 24
Registration of securities for employees
4:32pm
8-K
283 8nr6ap8cabe
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
8-K
pi4 gaa5s0tv
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
EFFECT
1oag6c6wcbddmq
22 Apr 24
Notice of effectiveness
12:15am
ARS
ln7pvfomufneqx4cng
18 Apr 24
Annual report to shareholders
4:15pm
8-K
9cdlbnd svra
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
yhffyne
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
16nu2 xc5o5roxogsv
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am